Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Recruiting · NCT04904146 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Sezary syndrome, Skin and Connective Tissue Diseases, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma, skin disorder, skin neoplasm | Recruiting | Not stated | 2026-08-27 | NCT04904146 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lund University Hospital | 32 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lund University Hospital | Lund | Sweden | 4 |